Drug industry lobbyists are upset by a last-minute change made to the Senate reconciliation bill that states if drug makers refuse to pay the taxes imposed on them when they choose not to negotiate drug prices, all their products will be excluded from Medicare and Medicaid. But one health policy expert says the industry outcry is simply an attempt to fuel public contempt against Medicare price negotiation, noting the new language is standard in Medicare contracts. As part of Democrats’...